论文部分内容阅读
选取我院2011年1月～2012年12月80例频发短暂性脑缺血患者,随机分成观察组和对照组,观察组给予巴曲酶联合阿司匹林,对照组给予阿司匹林,对比分析两组患者临床治疗效果。结果观察组临床治疗总有效率为97.5%,对照组为87.5%;观察组短暂性脑缺血发作停止时间为41.2±15.7h,对照组为52.7±20.4h;两组临床治疗总有效率和短暂性脑缺血发作停止时间比较均具有明显差异,P<0.05。巴曲酶联合阿司匹林治疗频发短暂性脑缺血发作疗效安全可靠,起效较快,副作用较小,值得进一步研究和临床推广应用。
Eighty patients with frequent transient ischemic attack in our hospital from January 2011 to December 2012 were randomly divided into observation group and control group. Batroxobin and aspirin were given to the observation group and aspirin was given to the control group. Clinical treatment effect. Results The total effective rate of clinical observation was 97.5% in observation group and 87.5% in control group. The stopping time of transient ischemic attack in observation group was 41.2 ± 15.7h and that of control group was 52.7 ± 20.4h. The total effective rate of clinical treatment and There were significant differences in the stopping time of transient ischemic attack, P <0.05. Batroxobin combined with aspirin in the treatment of frequent transient ischemic attack is safe and reliable, with rapid onset and less side effects, which deserves further study and clinical application.